Global Finasteride Market Analysis and Forecast Report 2023-2031: Growth Opportunities in Emerging Markets
08 sept. 2023 09h43 HE
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Finasteride Market By Application, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
10 août 2023 09h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the...
Product Innovation Boosts Growth of Testosterone Replacement Therapy Market, Projected to Reach $1.85 Billion in 2023
26 juil. 2023 04h23 HE
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
24 juil. 2023 09h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or Testosterone Deficiency, is proud to...
Global Hormone Therapy Market Set to Reach $23.65 Billion by 2027 with Growing Demand for Innovative Treatments and Rising Hormone Imbalance Cases
24 juil. 2023 07h13 HE
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Hormone Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The market is projected to grow from $17.34...
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
20 juin 2023 08h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 20, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or testosterone deficiency, announced today...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
09 juin 2023 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...
Global Polycystic Ovary Syndrome Treatment Market Report 2023: Sector is Expected to Reach $1.5 Billion by 2030 at a CAGR of 4.9%
01 juin 2023 11h23 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome Treatment Market, By Drug Class, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 -...
HealthEd Academy Reports On The Latest Ketogenic Diet Study And Its Link To Boosting Testosterone By 25%
20 déc. 2022 09h00 HE
|
HealthEd Academy
Clark, New Jersey, Dec. 20, 2022 (GLOBE NEWSWIRE) -- HealthEd Academy was created by fitness and bodybuilding expert, Steve Price, to share his vast experience and knowledge on how you can gain...
Base Healthcare Launches Innovative Platform for Men with Testosterone Deficiency
18 oct. 2022 08h00 HE
|
Base Healthcare
RALEIGH, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Base Healthcare today announced the official launch of its subscription-based men’s virtual health platform, which focuses on foundational health and...